Cita APA

Sahebjam, S., Forsyth, P., Arrington, J., Jaglal, M., Tran, N. D., Etame, A. B., . . . Yu, M. (2017). ATIM-18. A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) WITH PEMBROLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA (NCT02313272). Neuro Oncol.

Citación estilo Chicago

Sahebjam, Solmaz, et al. "ATIM-18. A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) WITH PEMBROLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA (NCT02313272)." Neuro Oncol 2017.

Cita MLA

Sahebjam, Solmaz, et al. "ATIM-18. A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) WITH PEMBROLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA (NCT02313272)." Neuro Oncol 2017.